Home › Therapeutic areas › Neurology › Bipolar Disorder
Bipolar Disorder (6 companies)
Companies with an active program in Bipolar Disorder.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| GHRS | GH Research | NeurologyWomen's Health | 1 | Phase 2 | $1.28B | 4 |
| LBRX | LB Pharmaceuticals | Neurology | 1 | Phase 3 | $1.36B | 3 |
| NRXP | NRX Pharmaceuticals | Neurology Rare | 1 | Approved | $103M | 7 |
| RVPH | Reviva Pharmaceuticals | CardiovascularDermatology+2 Rare | 1 | Phase 3 | $4.8M | 10 |
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 2 | Approved | $231M | 27 |
| XENE | Xenon Pharmaceuticals | Neurology Rare | 1 | NDA Submitted | $3.79B | 9 |
No companies match.